Structures by: Schultheiss N.
Total: 79
NS 1 pentyl calixarene + acetonitrile
(C72H76N4O8)(C2H3N)3
Organic letters (2006) 8, 12 2607-2610
a=18.3708(7)Å b=18.3708(7)Å c=19.8745(15)Å
α=90.00° β=90.00° γ=90.00°
NS 14 pentyl calixarene (+ octanedioic acid)
(C72H76N4O8)2(CH4O)7
Organic letters (2006) 8, 12 2607-2610
a=23.3560(16)Å b=22.1519(16)Å c=25.5165(16)Å
α=90.00° β=94.302(4)° γ=90.00°
2-amino-4-methyl-6-(3-pyridyl)pyrimidine,4-nitrobenzoic acid
(C10H10N4)(C7H5NO4)
New Journal of Chemistry (2006) 30, 10 1452
a=6.8245(5)Å b=9.5538(7)Å c=12.6278(9)Å
α=77.174(4)° β=84.400(4)° γ=82.637(4)°
2-amino-4-(3-pyridyl)-6-methylpyrimidine, 4-hydroxybenzoic acid
(C10H10N4)(C7H6O3)
New Journal of Chemistry (2006) 30, 10 1452
a=8.3089(6)Å b=8.9991(7)Å c=11.1671(7)Å
α=85.733(4)° β=69.174(4)° γ=77.699(5)°
2-amino-4-(6-methoxy-3-pyridyl)-6-methylpyrimidine, 4-(Me2N)-PhCOOH
(C11H12N4O)(C9H11NO2)
New Journal of Chemistry (2006) 30, 10 1452
a=7.8442(12)Å b=8.8879(14)Å c=14.216(2)Å
α=101.607(2)° β=90.830(2)° γ=106.753(2)°
1-(3-methoxy-5-pyridyl)-2-(2-amino-6-methyl-4-pyrimidyl)ethyne, (NO2)2PhCOOH
(C13H12N4O)(C7H4N2O6)
New Journal of Chemistry (2006) 30, 10 1452
a=7.374(11)Å b=8.385(13)Å c=17.56(3)Å
α=93.51(10)° β=96.29(7)° γ=104.50(11)°
[1-(3-OMe-5-pyridyl)-2-(2-amino-4-methyl-6-pyrimidyl)-ethyne], 3-Me2N-PhCOOH
(C13H12N4O)(C9H11NO2)
New Journal of Chemistry (2006) 30, 10 1452
a=10.5742(19)Å b=14.599(3)Å c=13.519(3)Å
α=90.00° β=102.453(11)° γ=90.00°
2-amino-4-(3-pyridyl)-6-methylpyrimidine, Me5-PhCOOH
(C10H10N4)(C12H16O2)
New Journal of Chemistry (2006) 30, 10 1452
a=8.2088(7)Å b=8.7891(6)Å c=15.3371(12)Å
α=92.767(5)° β=105.536(4)° γ=115.332(4)°
(2-amino-4-(6-methoxy-3-pyridyl)-6-methylpyrimidine), (2,4-difluorobenzoic acid)
(C11H12N4O),(C7H4F2O2)
New Journal of Chemistry (2006) 30, 10 1452
a=33.158(4)Å b=7.3848(7)Å c=14.1634(16)Å
α=90.00° β=106.439(6)° γ=90.00°
Bis[N-(3-pyridyl)acetamide], 1,4-diiodotetrafluorobenzene
(C7H8N2O)2(C6F4I2)
CrystEngComm (2008) 10, 12 1816
a=4.2616(9)Å b=29.232(6)Å c=17.734(4)Å
α=90.00° β=90.860(4)° γ=90.00°
2-(4-pyridyl)benzimidazole, 1,4-diiodotetrafluorobenzene, methanol
(C12H9N3)(C6F4I2)(CH4O)
CrystEngComm (2008) 10, 12 1816
a=9.0808(7)Å b=16.3144(12)Å c=13.6934(9)Å
α=90.00° β=91.057(4)° γ=90.00°
Bis{N-[(3-pyridyl)methyl]acetamide}, 1,4-diiodotetrafluorobenzene
(C8H10N2O)2(C6F4I2)
CrystEngComm (2008) 10, 12 1816
a=4.845(2)Å b=9.716(4)Å c=13.075(6)Å
α=104.096(6)° β=98.360(6)° γ=91.246(6)°
4-(pyrazol-3-yl)pyridine, 1,4-diiodotetrafluorobenzene
(C8H7N3)(C6F4I2)
CrystEngComm (2008) 10, 12 1816
a=7.1917(5)Å b=24.644(2)Å c=8.7269(7)Å
α=90.00° β=100.535(5)° γ=90.00°
[(5-OMe-3-pyridyl)(3-pyridyl)ethyne]4, [1,4-I2-F4-benzene]4
(C13H10N2O)4(C6F4I2)3
CrystEngComm (2008) 10, 12 1816
a=7.6881(4)Å b=14.8996(8)Å c=15.3296(8)Å
α=72.1600(10)° β=88.3640(10)° γ=88.5080(10)°
(pyridine-3,5-COOH) (2-AcNH-pyr)2, (1,4-I2-F4-benzene)2
(C7H5NO4)(C7H8N2O)2(C6F4I2)2
CrystEngComm (2008) 10, 12 1816
a=30.345(2)Å b=4.1878(3)Å c=16.6946(12)Å
α=90.00° β=90.00° γ=90.00°
(5-methoxy-3,3'-bipyridyl)2, (1,4-diiodotetrafluorobenzene)3
(C11H10N2O)2(C6F4I2)3
CrystEngComm (2008) 10, 12 1816
a=7.2012(7)Å b=17.6878(15)Å c=17.7138(16)Å
α=89.927(4)° β=82.869(7)° γ=88.275(6)°
205596 (3631-97-01)
(C8H10N4O2)(C9H8O3)
CrystEngComm (2011) 13, 2 611
a=6.5225(4)Å b=10.6474(6)Å c=23.2444(14)Å
α=90.00° β=93.983(2)° γ=90.00°
1-(4-pyridyl)-2-(2,3,5,6-F4-4-I-phenyl)ethene
(C13H6F4NI)
CrystEngComm (2007) 9, 5 421
a=12.0266(5)Å b=10.2443(4)Å c=4.9988(2)Å
α=90.00° β=90.00° γ=90.00°
N7 Cu(F6-acac)2 (1-(4-pyridyl)-2-(2,3,5,6-F4-4-Br- phenyl)ethene)2
Cu(C5HO2F6)2(C13H6F4NBr)2
CrystEngComm (2007) 9, 5 421
a=8.9889(3)Å b=9.0836(3)Å c=12.9622(5)Å
α=88.061(2)° β=86.489(2)° γ=67.894(2)°
NSBrCo Co(F6-acac)2 (1-(4-pyridyl)-2-(2,3,5,6-F4-4-Br- phenyl)ethene)2
Co(C5HO2F6)2(C13H6F4NBr)2
CrystEngComm (2007) 9, 5 421
a=8.9245(4)Å b=9.0077(3)Å c=13.0921(5)Å
α=86.370(2)° β=86.442(2)° γ=70.214(2)°
N3 Cu(F6-acac)2 (1-(4-pyridyl)-2-(2,3,5,6-F4-4-I- phenyl)ethene)2
Cu(C5HO2F6)2(C13H6F4NI)2
CrystEngComm (2007) 9, 5 421
a=9.0352(4)Å b=9.0357(4)Å c=13.2174(6)Å
α=87.447(2)° β=88.530(2)° γ=69.506(2)°
3S (aminopyridyl)ethynylcavitand, NO22PhCOOH
(C80H80N8O8)(C7H4N2O6)4(C2H3N)2.45(C2H5O)0.55
CrystEngComm (2007) 9, 3 211
a=14.636(3)Å b=17.062(3)Å c=25.079(4)Å
α=76.787(10)° β=85.972(12)° γ=64.566(9)°
NS6S (6-amino-3-pyridyl)ethynyl cavitand, glutaric acid
(C5H8O4)2(C80H80N8O8)(C8H10)1.2(C2H3N)
CrystEngComm (2007) 9, 3 211
a=12.7783(9)Å b=24.5634(18)Å c=29.317(2)Å
α=90.00° β=90.00° γ=90.00°
Tetra-(3-pyridyl)ethynyl calixarene
(C80H76N4O8)(C2H3N)(H2O)2
CrystEngComm (2006) 8, 7 502
a=25.359(2)Å b=22.2099(19)Å c=12.1129(10)Å
α=90.00° β=90.00° γ=90.00°
Hexyl bromo calixarene, acetonitrile
(C52H60O8I4)(C2H3N)
CrystEngComm (2006) 8, 7 502
a=19.045(3)Å b=16.627(2)Å c=18.618(3)Å
α=90.00° β=118.047(8)° γ=90.00°
3631-86-02 (205289)
(C8H10N4O2)2(C9H8O3)(O)0.2
CrystEngComm (2011) 13, 2 611
a=8.1475(7)Å b=11.2176(9)Å c=14.8517(13)Å
α=75.956(2)° β=84.712(2)° γ=73.340(2)°
C196H214B2Cl8F8O17P4Pd2
C196H214B2Cl8F8O17P4Pd2
Dalton Transactions (2009) 32 6296-6298
a=21.6920(10)Å b=19.2170(10)Å c=23.367(3)Å
α=90.00° β=95.225(8)° γ=90.00°
Bis(2-amino-4-(3-pyridyl)-6-methylpyrimidine) mu- (OAc)4dicopper(ii)
(C10H10N4)2Cu2(C2H3O2)4
Dalton transactions (Cambridge, England : 2003) (2006) 13 1627-1635
a=8.0282(5)Å b=10.6399(7)Å c=18.9041(13)Å
α=90.00° β=99.3600(10)° γ=90.00°
Bis(2-amino-4-(3-pyridyl)-6-methoxypyrimidine) mu-(OAc)4 dicopper(ii)
(C10H10N4O)2Cu2(C2H3O2)4
Dalton transactions (Cambridge, England : 2003) (2006) 13 1627-1635
a=8.2800(6)Å b=9.3983(6)Å c=11.2233(7)Å
α=71.144(4)° β=81.585(4)° γ=79.240(4)°
(2-amino-4-(3-pyridyl)-6-methoxypyridine)2, (2- fluorobenzoate)4 Cu2
(C10H10N4O1)2(C7H4O2F)4Cu2
Dalton transactions (Cambridge, England : 2003) (2006) 13 1627-1635
a=10.1310(9)Å b=10.5499(8)Å c=12.2936(9)Å
α=64.853(5)° β=86.149(5)° γ=67.896(4)°
(2-amino-4-(3-pyridyl)-6-methylpyridine)2, (2FPhCOO)4 Cu2
(C10H10N4)2Cu2(C7H4O2F)4
Dalton transactions (Cambridge, England : 2003) (2006) 13 1627-1635
a=21.3553(18)Å b=17.9389(15)Å c=11.4887(9)Å
α=90.00° β=90.742(5)° γ=90.00°
1-(2-NH2-5-pyridyl)-2-(3-pyridyl)-ethyne, (CH3COO)4Cu2
(C12H9N3)Cu2(C2H3O2)4
Dalton transactions (Cambridge, England : 2003) (2006) 13 1627-1635
a=8.1368(11)Å b=8.3062(11)Å c=8.7490(12)Å
α=86.244(3)° β=80.480(3)° γ=80.539(3)°
1-(2-NH2-5-pyridyl)-2-(3-pyridyl)-ethyne, (2FPhCOO)4Cu2
(C12H9N3)Cu2(C7H4O2F)4
Dalton transactions (Cambridge, England : 2003) (2006) 13 1627-1635
a=9.3471(9)Å b=15.5850(15)Å c=12.9025(11)Å
α=90.00° β=104.714(7)° γ=90.00°
1-(2-NH2-4-pyrimidyl)-2-(3-methoxy-5-pyridyl)ethyne (AcO)4Cu2 (EtO).6 (CH3CN).8
(C34H36Cu2N8O10)(C2H5O)0.6(C2H3N)0.8
Dalton transactions (Cambridge, England : 2003) (2006) 13 1627-1635
a=7.6304(13)Å b=11.3870(19)Å c=12.341(2)Å
α=76.216(3)° β=84.191(3)° γ=79.459(3)°
(2-amino-4-(6-methoxy-3-pyridyl)-6-methylpyrimidine), Me5-PhCOOH
(C11H12N4O)(C12H16O2)
New Journal of Chemistry (2006) 30, 10 1452
a=5.3534(5)Å b=12.6941(12)Å c=15.1880(14)Å
α=87.7550(10)° β=82.9210(10)° γ=87.542(2)°
[1-(3-OMe-5-pyridyl)-2-(2-amino-4-methyl-6-pyrimidyl)-ethyne], NO2PhCOOH
(C13H12N4O)(C7H5NO4)
New Journal of Chemistry (2006) 30, 10 1452
a=6.9157(12)Å b=6.9405(12)Å c=19.854(4)Å
α=87.646(3)° β=80.636(3)° γ=81.138(3)°
3189-81-07 minoxidil
(C9H15N5O)4(C4H6O6)2(H2O)
CrystEngComm (2010) 12, 3 742
a=19.283(2)Å b=9.7242(13)Å c=30.545(4)Å
α=90.00° β=105.048(7)° γ=90.00°
C22H38N10O8
C22H38N10O8
CrystEngComm (2010) 12, 3 742
a=21.2840(8)Å b=10.4088(4)Å c=13.8485(5)Å
α=90.00° β=117.311(2)° γ=90.00°
3189-76-02 minoxidil : adipic acid
(C9H15N5O)2(C6H10O4)
CrystEngComm (2010) 12, 3 742
a=11.6780(5)Å b=17.9581(8)Å c=13.6730(6)Å
α=90.00° β=94.615(2)° γ=90.00°
3189-80-04 minoxidil : benzoic acid
(C9H15N5O)(C7H6O2)
CrystEngComm (2010) 12, 3 742
a=12.0011(7)Å b=12.1067(7)Å c=12.5719(8)Å
α=66.822(2)° β=88.582(2)° γ=79.951(2)°
3189-76-06 minoxidil : 4-hydroxybenzoic acid
(C9H15N5O1)3(C7H6O3)2(H2O1)2
CrystEngComm (2010) 12, 3 742
a=17.8421(9)Å b=11.7743(6)Å c=21.9811(12)Å
α=90.00° β=102.245(2)° γ=90.00°
3262-11-02 minoxidil : 1-hydroxy-2-naphthoic acid
(C9H15N5O)(C11H8O3)2
CrystEngComm (2010) 12, 3 742
a=10.2003(5)Å b=30.8973(13)Å c=10.1214(4)Å
α=90.00° β=117.917(2)° γ=90.00°
3262-11-02 minoxidil : 1-hydroxy-2-naphthoic acid
(C9H15N5O)2(C11H8O3)(H2O)0.5
CrystEngComm (2010) 12, 3 742
a=9.6564(5)Å b=12.4660(7)Å c=13.9860(8)Å
α=107.291(3)° β=96.977(3)° γ=107.027(3)°
215077 (3694-81-02)
(C8H10N4O2)(C16H16O3)
CrystEngComm (2010) 12, 8 2436
a=17.4139(11)Å b=13.3693(8)Å c=18.4844(10)Å
α=90.00° β=90.492(2)° γ=90.00°
205650
(C15H12N2O1)(C16H16O3)
CrystEngComm (2010) 12, 8 2436
a=38.809(3)Å b=5.3921(4)Å c=26.7284(17)Å
α=90.00° β=117.306(3)° γ=90.00°
Hexyl bromo calixarene, acetonitrile
(C52H60Br4O8)(C2H3N1)
Organic letters (2006) 8, 12 2607-2610
a=10.7767(7)Å b=11.6740(7)Å c=20.8192(13)Å
α=80.392(4)° β=86.826(4)° γ=76.503(3)°
Hexyl bromo calixarene, dichloromethane
(C52H60Br4O8)(CH2Cl2)
Organic letters (2006) 8, 12 2607-2610
a=10.4432(15)Å b=15.049(2)Å c=16.320(2)Å
α=90.00° β=97.977(3)° γ=90.00°
Nifedipine--pyrazine (2/1)
C17H18N2O6,0.5(C4H4N2)
Acta Crystallographica Section E (2010) 66, 9 o2297-o2298
a=13.6278(14)Å b=9.1594(9)Å c=14.4432(14)Å
α=90.00° β=94.841(4)° γ=90.00°
NSoximeI 4-I-F4-PhCH=NOH
C7H2F4INO
Journal of the American Chemical Society (2007) 129, 13772-13773
a=4.38850(10)Å b=6.00010(10)Å c=31.9307(7)Å
α=90.00° β=93.9030(10)° γ=90.00°
MF-24-57 1-methyl-2-(4-pyridyl)benzimidazole, F5-benzaldehyde oxime
(C13H11N3)(C7H2F5NO)
Journal of the American Chemical Society (2007) 129, 13772-13773
a=6.8616(8)Å b=7.6589(8)Å c=34.632(4)Å
α=90.00° β=90.00° γ=90.00°
NSoximeBr 4-Br-F4-PhCH=NOH
C7H2BrF4NO
Journal of the American Chemical Society (2007) 129, 13772-13773
a=4.2896(3)Å b=5.9991(4)Å c=15.3706(10)Å
α=80.976(3)° β=84.419(4)° γ=88.344(3)°
MF-24-58 1-methyl-2-(4-pyridyl)benzimidazole, 4-Br-F4-PhCH=NOH
(C13H11N3)(C7H2F4NOBr)
Journal of the American Chemical Society (2007) 129, 13772-13773
a=6.8554(3)Å b=7.9485(4)Å c=34.9508(15)Å
α=90.00° β=90.00° γ=90.00°
MF-24-57 1-methyl-2-(4-pyridyl)benzimidazole, 4-I-F4-PhCH=NOH
(C13H11N3)(C7H2F4INO)
Journal of the American Chemical Society (2007) 129, 13772-13773
a=7.2257(5)Å b=10.0969(8)Å c=13.7520(11)Å
α=81.535(6)° β=81.846(4)° γ=74.495(4)°
Bis(F6-acac)bis[3-(2-amino-4-methylpyrimidin-6-yl)pyridine]copper(II) 1,2-dichloroethane
(C5H1O2F6)2(C10H10N4)2Cu1(C2H4Cl2)
Inorganic Chemistry (2005) 44, 4983-4991
a=8.2843(4)Å b=10.8750(5)Å c=11.7573(6)Å
α=113.0810(10)° β=94.4120(10)° γ=103.8330(10)°
Bis(1,3-Ph2propanedionato)-bis[3(2-amino-4-methoxypyrimidin-6-yl) pyridine]Co(II)
(C15H11O2)2(C10H10N4O)2Co
Inorganic Chemistry (2005) 44, 4983-4991
a=9.3368(7)Å b=10.3686(8)Å c=11.0609(8)Å
α=85.536(2)° β=79.677(2)° γ=83.026(2)°
1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne, Cu(F6-acac)2
(C13H12N4O)Cu(C5HF6O2)2
Inorganic Chemistry (2005) 44, 4983-4991
a=9.6243(11)Å b=10.4481(12)Å c=13.8822(15)Å
α=85.905(2)° β=86.300(2)° γ=74.690(2)°
[1-(2-amino-4-Methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne]2, Co(PhCOCCOPh)2
(C13H12N4O)2Co(C15H11O2)2
Inorganic Chemistry (2005) 44, 4983-4991
a=10.5076(5)Å b=10.7568(6)Å c=11.9544(6)Å
α=68.9160(10)° β=82.6200(10)° γ=69.1900(10)°
1-(2-amino-4-Methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne, Ni(Ph2acac)2
Ni(C13H12N4O)2(C15H11O2)2
Inorganic Chemistry (2005) 44, 4983-4991
a=10.4666(7)Å b=10.6669(7)Å c=11.9828(8)Å
α=68.678(4)° β=82.626(4)° γ=69.230(3)°
Ag1,(C2F3O2)1,(C20H20N2),(H2O)
Ag1,(C2F3O2)1,(C20H20N2),(H2O)
Inorganic Chemistry (2003) 42, 8886-8890
a=11.2008(6)Å b=19.9816(11)Å c=15.4750(9)Å
α=90.00° β=105.083(2)° γ=90.00°
(C16H12AgN2)1,(BF4)1,(CH3NO2)2
(C16H12AgN2)1,(BF4)1,(CH3NO2)2
Inorganic Chemistry (2003) 42, 8886-8890
a=15.404(2)Å b=19.967(3)Å c=14.279(2)Å
α=90.00° β=104.141(3)° γ=90.00°
Ag1,(C20H20N2),(CF3O3S)1,(C3H6O)
Ag1,(C20H20N2),(CF3O3S)1,(C3H6O)
Inorganic Chemistry (2003) 42, 8886-8890
a=18.031(3)Å b=18.672(3)Å c=14.466(2)Å
α=90.00° β=90.491(4)° γ=90.00°
C52H40Ag6F18N4O12),2(C7H8)
C52H40Ag6F18N4O12),2(C7H8)
Inorganic Chemistry (2003) 42, 5304-5310
a=11.7717(6)Å b=24.9539(12)Å c=12.8210(6)Å
α=90.00° β=110.828(2)° γ=90.00°
C84H80Ag2F6N8O4
C84H80Ag2F6N8O4
Inorganic Chemistry (2003) 42, 5304-5310
a=9.4603(6)Å b=13.3544(8)Å c=14.7099(9)Å
α=82.780(2)° β=84.554(2)° γ=75.649(2)°
C22H20AgF3N2O2
C22H20AgF3N2O2
Inorganic Chemistry (2003) 42, 5304-5310
a=4.5443(4)Å b=14.3428(13)Å c=15.3996(14)Å
α=89.317(2)° β=84.737(2)° γ=87.086(2)°
(C32H24Ag1N4)1,(B1F4)1,(C1H3N1O2)
(C32H24Ag1N4)1,(B1F4)1,(C1H3N1O2)
Inorganic Chemistry (2003) 42, 5304-5310
a=3.8099(3)Å b=11.8095(9)Å c=16.4554(12)Å
α=84.265(2)° β=83.833(2)° γ=85.556(2)°
2-amino-4-methyl-6-(3-pyridyl)pyrimidine
C10H10N4
Crystal Growth & Design (2007) 7, 11 2324
a=6.9426(4)Å b=7.2048(5)Å c=9.3201(6)Å
α=92.459(4)° β=91.380(4)° γ=107.319(4)°
2-amino-4-(4-pyridyl)-6-methylpyrimidine
C10H10N4
Crystal Growth & Design (2007) 7, 11 2324
a=5.5629(4)Å b=7.4679(6)Å c=22.1080(18)Å
α=90.00° β=90.00° γ=90.00°
2-amino-4-(6-methoxy-3-pyridyl)-6-methylpyrimidine
C11H12N4O
Crystal Growth & Design (2007) 7, 11 2324
a=11.6368(8)Å b=7.2494(5)Å c=24.7339(17)Å
α=90.00° β=90.00° γ=90.00°
1-(2-aminopyrimidin-5-yl)-2-(pyrid-3-yl)ethyne
C12H9N3
Crystal Growth & Design (2007) 7, 11 2324
a=8.6286(6)Å b=15.3249(10)Å c=8.1780(6)Å
α=90.00° β=115.5070(10)° γ=90.00°
1-(6-amino-3-pyridyl)-2-(4-{benzimidazol-1-yl}phenyl) ethyne
C21H16N4
Crystal Growth & Design (2007) 7, 11 2324
a=5.132(2)Å b=10.542(4)Å c=15.457(6)Å
α=83.343(19)° β=89.94(3)° γ=88.14(3)°
NS10b 2-amino-4-(4-pyridyl)-6-methylpyrimidine
C10H10N4
Crystal Growth & Design (2007) 7, 11 2324
a=12.7944(9)Å b=12.9712(9)Å c=23.1035(15)Å
α=90.00° β=90.246(4)° γ=90.00°
1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne, (CH2Cl2)0.5
(C13H12N4O)(C1H2CL2)0.5
Crystal Growth & Design (2007) 7, 11 2324
a=7.2432(8)Å b=7.7893(8)Å c=12.6950(13)Å
α=107.292(2)° β=91.059(2)° γ=98.566(2)°
213357 (3694-54-01)
(C16H16O3)(C5H8O4)
Crystal Growth & Design (2011) 11, 7 2817
a=7.2644(3)Å b=32.8801(16)Å c=7.9819(4)Å
α=90.00° β=96.000(2)° γ=90.00°
3694-25-06 (209739)
(C16H16O3)2(C4H10N2)
Crystal Growth & Design (2011) 11, 7 2817
a=5.2586(7)Å b=11.7922(14)Å c=51.155(7)Å
α=90.00° β=90.00° γ=90.00°
3189-80-03 minoxidil and succinic acid
(C9H15N5O)2(C4H6O4)(H2O)2
CrystEngComm (2010) 12, 3 742
a=9.3818(4)Å b=10.4613(5)Å c=14.1476(7)Å
α=90.00° β=99.410(3)° γ=90.00°
204542
(C16H16O3)(C8H10N4O2)
CrystEngComm (2010) 12, 8 2436
a=17.424(2)Å b=26.809(4)Å c=18.546(2)Å
α=90.00° β=90.225(5)° γ=90.00°
(F6-acac)2[3-(2-amino-4-methoxypyrimidin-6-yl)pyridine]2Cu(II) (CHCl3)2
(C5HF6O2)2(C10H10N4O)2Cu(CHCl3)2
Inorganic Chemistry (2005) 44, 4983-4991
a=10.4149(6)Å b=12.1682(7)Å c=18.2488(10)Å
α=105.6980(10)° β=105.8970(10)° γ=93.1160(10)°
(C32H24AgN4)1,(NO3)1
(C32H24AgN4)1,(NO3)1
Inorganic Chemistry (2003) 42, 5304-5310
a=7.1361(6)Å b=30.910(2)Å c=11.9478(9)Å
α=90.00° β=90.00° γ=90.00°
C24H20Ag2F6N2O4
C24H20Ag2F6N2O4
Inorganic Chemistry (2003) 42, 5304-5310
a=10.5410(11)Å b=21.859(2)Å c=10.9825(11)Å
α=90.00° β=100.434(2)° γ=90.00°